KEVIN MELODY (IDM '17) has started a postdoctoral fellowship at UTMB-Galveston in a BSL-4 research group headed by Thomas Geisbert. Due to the security and proficiency needed to perform the work, Kevin will undergo extensive training before beginning high-containment pathogen-related research. Within this state-of-the-art facility, an extraordinary group of scientists are engaged in efforts to translate research ideas into products aimed at controlling emerging infectious diseases and defending our society against bioterrorism. The GNL has been designed to serve as a national resource, and will complement and enhance UTMB's decades of prominence in biomedical research - as well as provide a world renowned resource for training researchers in infectious diseases. As one of two National Biocontainment Laboratories constructed with funding awarded in October 2003 by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the GNL provides much needed research space and specialized research capabilities to develop therapies, vaccines, and diagnostic tests for naturally occurring emerging diseases such as SARS, West Nile encephalitis and avian influenza – as well as for microbes that might be employed by terrorists. Products likely to emerge from research and investigations within the GNL include novel diagnostic assays, improved therapeutics and treatment models, and preventative measures such as vaccines.